180 related articles for article (PubMed ID: 23814523)
1. Enrollment of patients with lung and colorectal cancers onto clinical trials.
Fouad MN; Lee JY; Catalano PJ; Vogt TM; Zafar SY; West DW; Simon C; Klabunde CN; Kahn KL; Weeks JC; Kiefe CI
J Oncol Pract; 2013 Mar; 9(2):e40-7. PubMed ID: 23814523
[TBL] [Abstract][Full Text] [Related]
2. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
[TBL] [Abstract][Full Text] [Related]
3. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
4. A population-based assessment of specialty physician involvement in cancer clinical trials.
Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
[TBL] [Abstract][Full Text] [Related]
5. Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.
Collins CL; Malvar J; Hamilton AS; Deapen DM; Freyer DR
Cancer; 2015 Dec; 121(24):4398-406. PubMed ID: 26393950
[TBL] [Abstract][Full Text] [Related]
6. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
[TBL] [Abstract][Full Text] [Related]
7. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
8. Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.
Kehl KL; Arora NK; Schrag D; Ayanian JZ; Clauser SB; Klabunde CN; Kahn KL; Fletcher RH; Keating NL
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217775
[TBL] [Abstract][Full Text] [Related]
9. Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.
Parsons HM; Penn DC; Li Q; Cress RD; Pollock BH; Malogolowkin MH; Wun T; Keegan THM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27426. PubMed ID: 30256525
[TBL] [Abstract][Full Text] [Related]
10. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
[TBL] [Abstract][Full Text] [Related]
11. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
[TBL] [Abstract][Full Text] [Related]
13. Patient enrollment onto clinical trials: the role of physician knowledge.
Gregg JR; Horn L; Davidson MA; Gilbert J
J Cancer Educ; 2014 Mar; 29(1):74-9. PubMed ID: 24163050
[TBL] [Abstract][Full Text] [Related]
14. Patients' expectations about effects of chemotherapy for advanced cancer.
Weeks JC; Catalano PJ; Cronin A; Finkelman MD; Mack JW; Keating NL; Schrag D
N Engl J Med; 2012 Oct; 367(17):1616-25. PubMed ID: 23094723
[TBL] [Abstract][Full Text] [Related]
15. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
16. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.
Somkin CP; Ackerson L; Husson G; Gomez V; Kolevska T; Goldstein D; Fehrenbacher L
J Oncol Pract; 2013 Nov; 9(6):e275-83. PubMed ID: 24151327
[TBL] [Abstract][Full Text] [Related]
17. Predictors of enrollment in lung cancer clinical trials.
Du W; Gadgeel SM; Simon MS
Cancer; 2006 Jan; 106(2):420-5. PubMed ID: 16342295
[TBL] [Abstract][Full Text] [Related]
18. Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
Weiner BJ; Jacobs SR; Minasian LM; Good MJ
J Oncol Pract; 2012 Sep; 8(5):287-91. PubMed ID: 23277765
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
[TBL] [Abstract][Full Text] [Related]
20. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
